Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,381,262
+$7,910,350 QoQ
Shares Held
452,671
+24.3% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#98
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. RPRX ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in RPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,381,262 | 452,671 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,470,912 | 364,205 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $9,879,666 | 255,685 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,770,877 | 220,263 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,730,640 | 75,788 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,623,447 | 84,274 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,788,759 | 70,120 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,536,993 | 54,330 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,269,872 | 48,156 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,528,976 | 50,345 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $418,314 | 14,892 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $395,726 | 14,581 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,334,146 | 43,401 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,268,218 | 35,199 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $894,257 | 22,628 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,558,901 | 38,798 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,477,956 | 35,156 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,075,645 | 27,609 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $959,027 | 24,066 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,056,870 | 56,914 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,350,020 | 106,124 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,563,644 | 35,847 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $19,351,479 | 386,643 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,236,814 | 29,399 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $17,785,320 | 366,330 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||